JADE BREEBACK: Open Payments
NPI 1922351188 · KERNERSVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,500 in 81 payments from 20 companies in 2025. Trend: 2023 $1,727 · 2024 $1,605 · 2025 $1,500
Food & beverage: $1,500
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $272 |
| ABBVIE INC. | 19 | $246 |
| PFIZER INC. | 10 | $136 |
| Otsuka America Pharmaceutical, Inc. | 5 | $114 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $85 |
| Abbott Laboratories | 3 | $84 |
| Lilly USA, LLC | 4 | $74 |
| Corcept Therapeutics | 2 | $62 |
| Vanda Pharmaceuticals Inc. | 3 | $60 |
| Ardelyx, Inc. | 3 | $58 |
Products named: VRAYLAR, REXULTI, BREZTRI, FARXIGA, CAPLYTA, FREESTYLE LIBRE 3, NURTEC ODT, Korlym.
Industry payments across NC — which companies pay providers there.
